A549 cells harbor a single nucleotide mutation G12S in KRAS gene (very rare mutation for NSCLC), which leads to the substitution of a glycine for a serine and confers constitutive activation of KRAS (59). Here, KRAS is linked to non-small cell lung carcinoma.